Usefulness of temazepam and zaleplon to induce afternoon sleep

Military Medicine

Volumn 171, Issue 10, 2006, Pages 998-1001

  Simons, Ries ^a   Koerhuis, Claudy L ^a   Valk, Pierre J L ^a   Van Den Oord, Marieke H A H ^b  

^a TNO   (Netherlands)

^b Center for Man in Aviation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC AGENT; PLACEBO; TEMAZEPAM; ZALEPLON;

ADULT; ALERTNESS; ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; HUMAN; HUMAN EXPERIMENT; MALE; MILITARY SERVICE; MUSCLE STRENGTH; NIGHT; NORMAL HUMAN; PERFORMANCE; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SHIFT WORKER; SLEEP INDUCTION; SOMNOLENCE;

EID: 33750060295     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.171.10.998     Document Type: Article

References (26)

1. French J, Neville KJ, Storm WF, Bisson RU, Boll P: Determinants of subjective fatigue for C-141 crews during operation Desert Storm, pp 17/1-12. NATO-AGARD-CP 547, Recent Advances in Long Endurance Operation of Aircraft. NATO-AGARD, Neuilly-sur-Seine, France, 1993;
2. Perelli LP: Fatigue stressors in simulated long-duration flight. Technical report 80-49. Brooks AFB, TX, USAF School of Aerospace Medicine, 1980.
3. Penetar DM, Belenky G, Garrigan JJ, Redmond DP: Triazolam impairs learning and fails to improve sleep in a long range aerial deployment. Aviat Space Environ Med 1989; 60: 594-8.
4. Caldwell JA: Fatigue in the aviation environment: an overview of the causes and effects as well as recommended countermeasures. Aviat Space Environ Med 1997; 68: 932-8.
5. Simons M, Valk PJL: Early starts: effects on sleep, alertness and vigilance, pp 6/1-5. AGARD-CP-599; Neuilly-sur-Seine, France, NATO-AGARD, 1998.
6. Dinges DF, Whitehouse WG, Orne EC, Orne MT,: The benefits of a nap during prolonged work and wakefulness. Work Stress 1988; 2: 139-52.
7. Nicholson AN, Stone BM,: Sustained air operations: prolonged duty overnight, pp 1/1-14. AGARD-CP-599. Neuilly-sur-Seine, France, NATO-AGARD, 1998.
8. Nicholson AN, Stone BM: Hypnotics and stimulants in operational settings, pp K1-1/K1-8. RTO-MP-31. Individual Differences in the Adaptability to Irregular Rest-Work Rhythms/Status of the Use of Drugs in Sleep-Wakefulness Management. Neuilly-sur-Seine, France, NATO-RTO, 2000.
9. Simons M, Valk PJL: Sleep and alertness management during military operations: questions to be answered, pp 8-1/8-8. RTO-MP-31. Individual Differences in the Adaptability to Irregular Rest-Work Rhythms/Status of the Use of Drugs in Sleep-Wakefulness Management. Neuilly-sur-Seine, France, NATO-RTO, 2000.
10. Drake CL, Roehrs TA, Mangano RM, Roth T: Dose-response effects of zaleplon as compared with triazolam (0.25 mg) and placebo in chronic primary insomnia. Hum Psychopharmacol 2000; 15: 595-604.
11. Whitmore JN, Fischer JR, Jr, Storm WF: Hypnotic efficacy of zaleplon for daytime sleep in rested individuals. Sleep 2004; 27: 895-8.
12. Meijman TF, De Vries GM, De Vries-Griever AHG, Kampman R: The evaluation of the Groningen Sleep Quality Scale. Department for Experimental and Occupational Psychology, Biological Centre, University of Groningen, Groningen, The Netherlands, 1987.
13. Sadeh A, Alster J, Urbach D, Lavie P: Actigraphically based automatic bedtime sleep-wake scoring: validity and clinical applications. J Ambul Monit 1989; 2: 209-16.
14. Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft M, Pollak CP: The role of actigraphy in the study of sleep and circadian rhythms. Sleep 2003; 26: 342-92.
15. Hoddes E, Zarcone V, Smythe H, Philips R, Dement WC: Quantification of sleepiness: a new approach. Psychophysiology 1973; 10: 431-6.
16. Valk PJL, Simons M, Struyvenberg PAA, Kruit J, Van Berge Henegouwen M: Effects of a single dose of loratadine on flying ability under conditions of simulated cabin pressure. Am J Rhinol 1997; 11: 27-33.
17. Valk PJL, vanRoon DB, Simons RM, Rikken G: Desloratadine shows no effect on performance during 6 h at 8000 ft simulated cabin altitude. Aviat Space Environ Med 2004; 75: 433-8.
18. Arnegard RJ: Operator strategies under varying conditions of workload. NASA CR-4385. Hampton, VA, Langley Research Center, National Aeronautics and Space Administration, 1991.
19. Comstock JR, Amegard RJ: The Multi-Attribute Task battery for human operator workload and strategic behavior research. NASA TM-104174. Hampton, VA, Langley Research Center, National Aeronautics and Space Administration, 1992.
20. Vos JA: Static and dynamic power measurements. University of Ghent, PhD Thesis, Ghent, Belgium, 1976.
21. Caldwell JL, Prazinko BF, Rowe T, Norman D, Hall KK, Caldwell JA: Improving daytime sleep with temazepam as a countermeasure for shift lag. Aviat Space Environ Med 2003; 74: 153-63.
22. Wesnes K, Warburton DM: Effects of temazepam on sleep quality and subsequent mental efficiency under normal sleeping conditions and following delayed sleep onset. Neuropsychobiology 1986; 15: 187-91.
23. Levine B, Roehrs T, Stepanski E, Zorick F, Roth T: Fragmenting sleep diminishes its recuperative value. Sleep 1987; 10: 590-9.
24. Simons M, De Ree JJD, Valk PJL, Veldhuijzen van Zanten OBA, D'Huyvetter K: Quantity and quality of onboard and layover sleep: effects on crew performance and alertness. Technical Memorandum RD-31-94. Soesterberg, The Netherlands, Netherlands Aerospace Medical Centre, 1994.
25. Aritake S, Uchiyama M, Tagaya H, et al: Time estimation during nocturnal sleep in human subjects. Neurosci Res 2004; 49: 387-93.
26. Porcù S, Bellatreccia A, Ferrara M, Casagrande M: Performance, ability to stay awake, and tendency to fall asleep during the night after a diurnal sleep with temazepam or placebo. Sleep 1997; 20: 535-41.